Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults

NCT06938763 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: J4
DRUG: Placebo

Sponsor

Academia Sinica, Taiwan